Adaptimmune Therapeutics plc

(ADAP) Trade

By |

Profile

Adaptimmune Therapeutics PLC along with its subsidiaries is a clinical-stage biopharmaceutical company. It is engaged in novel cancer immunotherapy products based on its T-cell receptor platform.

Contact Information

Website: www.adaptimmune.com
Email: will.roberts@adaptimmune.com
Main Phone: +44 1235430000
Address: 60 Jubilee Avenue
Address 2: Milton Park
State: Oxfordshire
City / Town: Abingdon
Country: GBR
Postal Code: OX14 4RY

Issuer Information

Exchange: NGS
CEO: James J. Noble
Employees: 390
NAICS: Pharmaceutical P
$ 11.71 $ -0.26 (-2.17%)
Last Price 11.71 Change $ -0.26 Change % -2.17 Tick N/A
Bid 9.80 Bid Size 200.00 Ask N/A Ask Size 0.00
Open 11.95 High 12.06 Low 11.64 Prev Close 11.97
Last Trade Volume 272,198 52 Wk Hi 14.63 52 Wk Low 6.60
Market Cap 1.2 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 104,446,756.00 EPS (TTM) -1.03 PE Ratio N/A Exchange NGS
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 20 20 20 20
Low Target Price Estimate 10 10 10 10
Mean Target Price Estimate 16 15 15 16
Standard Deviation 4.69 4.12 4.12 4.69
Date of Most Recent Estimate 06/04/18 05/09/18 05/09/18 06/04/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 3 3 3 3
Moderate Buy 1 1 1 1
Hold 1 1 1 1
Moderate Sell 1 1 1 1
Strong Sell 0 0 0 0
Mean Rec. 2 2 2 2